Evidence map›Paper›PMID 7739519›Full record

ArticleMolecular and cellular biology1995

Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA.

A K Talley, S Dewhurst, S W Perry, S C Dollard, S Gummuluru, S M Fine, D New, L G Epstein, H E Gendelman, H A Gelbard

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04918719 (Randomized Placebo Controlled Trial of Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke), which is not on this map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
20.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04918719 phase2completednot on this mapstarted 2023, after this paper: background citation

Randomized Placebo Controlled Trial of Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke

TypeinterventionalSponsorLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterRan2023 to 2024Enrolled4ConditionsAcute Ischemic StrokeArmsAcetylcysteine, Dextrose in Water
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 303 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Overview on the Effects ofMolecules (Basel, Switzerland) · 2018
    Review
  14. Article
  15. Article
  16. The Role of Shed PrPJournal of immunology (Baltimore, Md. : 1950) · 2017
    Article
  17. Article
  18. Epigenetic regulation of peroxiredoxins: Implications in the pathogenesis of cancer.Experimental biology and medicine (Maywood, N.J.) · 2017
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

A K TalleyDepartment of Neurology (Child Neurology Division), University of Rochester Medical Center, New York 14642, USA.
S Dewhurst
S W Perry
S C Dollard
S Gummuluru
S M Fine
D New
L G Epstein
H E Gendelman
H A Gelbard
University of Rochester Medical Center · USUniversity of Nebraska Medical Center · US

Funding

Role of EAAT2 and AEG-1 in Astrocyte Dysfunction and NeurodegenerationP01NS031492 · NINDS · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI SHARER, LEROY R · 1993 to 2007
$10.9M
ANALYSIS OF AN ACUTELY LETHAL ISOLATE OF SIVF32AI008894 · NIAID · UNIVERSITY OF ROCHESTER · PI DOLLARD, SHIELA C · 1993 to 1994
–
PATHOGENESIS AND THERAPY FOR LENTIVIRUSESK04AI001240 · NIAID · UNIVERSITY OF ROCHESTER · PI DEWHURST, STEPHEN · 1994 to 1998
–
NIAID NIH HHS F32-AI08894NIAID NIH HHS KO4-AI01240NINDS NIH HHS P01 NS31492-01
6 · The paper itself

Abstract

Tumor necrosis factor alpha (TNF-alpha) is a candidate human immunodeficiency virus type 1-induced neurotoxin that contributes to the pathogenesis of AIDS dementia complex. We report here on the effects of exogenous TNF-alpha on SK-N-MC human neuroblastoma cells differentiated to a neuronal phenotype with retinoic acid, TNF-alpha caused a dose-dependent loss of viability and a corresponding increase in apoptosis in differentiated SK-N-MC cells but not in undifferentiated cultures. Importantly, intracellular signalling via TNF receptors, as measured by activation of the transcription factor NF-kappa B, was unaltered by retinoic acid treatment. Finally, overexpression of bcl-2 or crmA conferred resistance to apoptosis mediated by TNF-alpha, as did the addition of the antioxidant N-acetylcysteine. These results suggest that TNF-alpha induces apoptosis in neuronal cells by a pathway that involves formation of reactive oxygen intermediates and which can be blocked by specific genetic interventions.

Indexed as

Viral ProteinsAcetylcysteineAIDS Dementia ComplexAntioxidantsApoptosisCell DifferentiationCell LineCulture Media, ConditionedHIV-1HumansNeuronsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2SerpinsTretinoinTumor Necrosis Factor-alphaAcetylcysteineAntioxidantsCulture Media, Conditionedinterleukin-1beta-converting enzyme inhibitorProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2SerpinsTretinoinTumor Necrosis Factor-alphaViral Proteins

Identifiers

PMID7739519
PMCPMC230464
OpenAlexW2150627157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.